Work

Feasibility and effects of galantamine on cognition in humans with cannabis use disorder

Year: 2019

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Pharmacology Biochemistry and Behavior

DOI: 10.1016/j.pbb.2019.05.004

Authors: Dawn E. Sugarman, Joao P. De Aquino, James Poling, Mehmet Sofuoglu

Institutions: Harvard University, McLean Hospital, Yale University, VA Connecticut Healthcare System

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Drug Abuse, National Center for Advancing Translational Sciences

Awards: G1044130170, Human Laboratory Studies for Stimulant Addiction, Yale Clinical and Translational Science Award

OpenAlex ID: W2944178227

FWCI: 1.045

Cites: 56

Cited by: 13

Related to: 10